ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy.

Saved in:
Bibliographic Details
Title: ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy.
Authors: Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Cursano G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Scafetta R; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Giachetti PPMB; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Concardi A; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., De Camilli E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., D'Ercole M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Mane E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Frascarelli C; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Marra A; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Gandini S; Department of Experimental Oncology, IEO, IRCCS, Milan, Italy., Pepe F; Department of Public Health, University Federico II of Naples, Naples, Italy., Scagnoli S; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy., Rossi SM; Operative Research Unit of Anatomical Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Medicine, Research Unit of Anatomical Pathology, Università Campus Bio-Medico di Roma, Rome, Italy., Troiano R; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Speziale E; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., De Angelis C; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Troncone G; Department of Public Health, University Federico II of Naples, Naples, Italy., Malapelle U; Department of Public Health, University Federico II of Naples, Naples, Italy., Perrone G; Operative Research Unit of Anatomical Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Medicine, Research Unit of Anatomical Pathology, Università Campus Bio-Medico di Roma, Rome, Italy., Botticelli A; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy., Viale G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Guerini Rocco E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy. elena.guerinirocco@ieo.it.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. elena.guerinirocco@ieo.it., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Fusco N; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Source: Breast cancer research : BCR [Breast Cancer Res] 2025 May 14; Vol. 27 (1), pp. 79. Date of Electronic Publication: 2025 May 14.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1465-542X
DOI:10.1186/s13058-025-02020-x